BluePath Capital Management’s uniQure QURE Stock Holding History

BluePath Capital Management’s Portfolio QURE Stock Details QURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,988	Closed	-$26.8K	–	274
2023 Q3	$26.8K	Buy	+3,988	New	+$35.9K	0.02%	308

Other funds holding QURE

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BluePath Capital Management's QURE Position: Q4 2023 in Review

BluePath Capital Management sold out of uniQure (QURE) in Q4 2023, closing a stake of 3,988 shares — an estimated $26.8K sold.

BluePath Capital Management first reported a position in QURE in Q3 2023 and held it in 1 quarter. The position peaked at $26.8K in Q3 2023. 144 funds tracked by Wall St. Rank hold QURE as of Q4 2023.

BluePath Capital Management reported no remaining uniQure position as of Q4 2023 after selling out during the quarter.
BluePath Capital Management sold 3,988 uniQure shares in Q4 2023, an estimated $26.8K.
BluePath Capital Management first reported a position in uniQure in Q3 2023 and held it in 1 quarter.
BluePath Capital Management's uniQure position peaked at $26.8K in Q3 2023.
144 funds tracked by Wall St. Rank held uniQure as of Q4 2023.

Based on BluePath Capital Management's 13F filing for Q4 2023, filed 11 Jan 2024.